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Optimal curation of human diseases requires an ontology or structured vocabulary that contains terms familiar to end
users, is robust enough to support multiple levels of annotation granularity, is limited to disease terms and is stable enough
to avoid extensive reannotation following updates. At Mouse Genome Informatics (MGI), we currently use disease terms
from Online Mendelian Inheritance in Man (OMIM) to curate mouse models of human disease. While OMIM provides highly
detailed disease records that are familiar to many in the medical community, it lacks structure to support multilevel
annotation. To improve disease annotation at MGI, we evaluated the merged Medical Subject Headings (MeSH) and
OMIM disease vocabulary created by the Comparative Toxicogenomics Database (CTD) project. Overlaying MeSH onto
OMIM provides hierarchical access to broad disease terms, a feature missing from the OMIM. We created an extended
version of the vocabulary to meet the genetic disease-specific curation needs at MGI. Here we describe our evaluation of




The ability to curate disease-related data is imperative for
many databases. There is a growing pool of available dis-
ease-related data, increasing interest from end users and
pressure from funding agencies to make clear connections
between the data from model organisms and the human
diseases they reference. There are a number of disease
vocabularies and ontologies that may be used for the pur-
pose of annotating disease models each with its own ad-
vantages and disadvantages (1).
Background
At Mouse Genome Informatics (MGI) (2), disease model an-
notations currently are made by associating specific mouse
genotypes to Online Mendelian Inheritance in Man (OMIM)
disease terms (OMIM.org). MGI filters the OMIM phenotype
terms to exclude those that are not describing human dis-
eases (e.g. HAIR MORPHOLOGY 2, 139450) and loads only
the OMIM disease terms. Annotations are made from pub-
lished experimental-based assertions of the relationship be-
tween a mouse model and a human disease. These
assertions often relate a mouse model to a general disease
class. For example, Iwamoto et al. (3) stated ‘We have
demonstrated that the disruption of the AC5 [official
symbol ADCY5] gene led to a major deficit in AC activity
in a striatal specific manner and an abnormal coordination
[...that] mimicked Parkinson’s disease.’ While OMIM has
over 20 different Parkinson disease sub-type records,
there is no record for the general term Parkinson disease
and none of the OMIM Parkinson disease records are asso-
ciated with the human gene ADCY5. If OMIM had an
ADCY5-specific Parkinson disease record, MGI could
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annotate etiologically distinct mouse models to an OMIM
record unless the publication specifically refers to the exact
disease. Thus, the model described by Iwamoto et al.
cannot be annotated directly to any OMIM term. Such
models are instead annotated in structured text fields
(Figure 1). While text annotations allow users to view the
model statements, the ability to search for and compute
over these annotations is extremely limited. In addition,
descriptions of complicated models involving multiple mu-
tations on complex genetic backgrounds can be difficult to
describe clearly in such structured text form. Further, be-
cause these text annotations are visually separated from
the phenotypic annotations for the same model in the
web display, connections between phenotype and disease
may be difficult for users to identify.
OMIM has been used by MGI for disease associations be-
cause of the presence of detailed disease descriptions, links
between disease records and human genes and familiarity
to biomedical researchers. However, the absence of hier-
archical structure in OMIM means that there is no grouping
mechanism beyond text searching to allow users to view all
models of a disease such as Parkinson disease. Instead, users
must collate models from each of the specific OMIM
Parkinson disease records and models annotated in struc-
tured text in order to create a complete list (Figure 2). This
situation is exacerbated as OMIM adds more records for
specific types of a disease and the numbers of mouse
models of human disease increase.
Strategy
MGI sought to identify a disease ontology or vocabulary to
improve curation of mouse models of human disease.
General criteria for selecting a disease ontology have
been defined previously (1, 4). The criteria considered
Figure 1. Allele detail page for Adcy5
tm1Yish, arrow indicates the structured text disease annotation in the ‘Notes’ section of the
page.
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ease include several of those described by Bodenreider and
Burgun (1) i.e. coverage of diseases, regular maintenance,
support for reasoning and open availability. Additional cri-
teria include stability of the vocabulary, percentage of
terms with definitions, inclusion of synonyms and familiar-
ity of the vocabulary to the user community. A final and
necessary consideration for MGI curatorial representations
is the incorporation of OMIM as part of the terminology.
These additional criteria are generally applicable to the
use of any ontology. A stable ontology avoids the need for
extensive and repeated recuration of data. Deep synonym
coverage allows for easier identification of diseases from
the literature and for more effective searching of the
data by users. Definitions provide a description of the dis-
ease to aid in understanding of the disease term and pro-
vide a basis for comparison to the model. Familiarity of the
user community improves the likelihood that users will
readily find the disease representation they are seeking.
In addition, for MGI, OMIM links were considered essential
for the migration of existing annotations to the new
vocabulary, to meet end user needs and to maintain
access to the human disease to human gene annotations
provided by OMIM.
Of the existing disease ontologies and vocabularies, two
were identified as containing at least some links to OMIM;
the Disease Ontology (DO) (5) and the MErged DIsease
voCabulary (MEDIC) developed at the Comparative
Toxicogenomics Database (CTD) (6). While the DO may
grow into a better long-term solution, it was, at the time
we undertook this evaluation, not nearly mature or robust
enough to be useful for curating disease data. The DO was
being extensively revised (which negatively impacts its sta-
bility), only 11% of the terms had definitions (as of 21 June
2010), and while OMIM IDs were being added, many were
still missing and there was uneven mapping of OMIM dis-
eases within the DO (Drs L. Schriml and W. Kibbe, personal
communication). Therefore, we undertook an extensive
evaluation of MEDIC.
CTD MEDIC
CTD created, implemented and maintained MEDIC, a dis-
ease vocabulary created by merging disease terms from
OMIM with the disease subsections in Medical Subject
Headings (MeSH) (Davis, AP et al., submitted for publica-
tion). Briefly, MeSH is a structured, hierachical thesaurus
created and maintained by the National Library of
Medicine to index journal articles (www.nlm.nih.gov/
mesh/). Two subsections of MeSH were used to create the
vocabulary: Diseases [C] and Mental Disorders [F03]. OMIM
terms were limited to those with an associated National
Center for Biotechnology Information accession ID (gene
or locus). The merged vocabulary effectively is the MeSH
hierarchy onto which all selected OMIM terms have been
mapped based on lexical similarity or symptom matching
for OMIM terms lacking a lexical match (i.e. OMIM 101000,
NEUROFIBROMATOSIS, TYPE II merged with MeSH
D016518, Neurofibromatosis 2). Mapped OMIM terms
were either merged with a MeSH term(s) or made a
subterm (child) of a MeSH term(s). The use of
Figure 2. Partial search results from MGI for the keyword ‘Parkinson’. Users currently have no simple way to create a unified set
of all mouse models of Parkinson disease.
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mapping, but curation issues can result, and this is discussed
more fully below.
CTD loads the vocabularies from MeSH and OMIM on a
monthly basis and quality control processes identify
changes to these vocabularies, which require curation of
the merged vocabulary. This vocabulary is freely available
from CTD and can be viewed on the web at http://ctd.mdibl
.org/voc.go?type=disease.
Results and discussion
MEDIC was evaluated to determine its suitability for use
in curation of mouse models of human disease by MGI.
We considered the breadth and depth of disease terms
in the vocabulary in relation to disease models in MGI.
In addition, we considered the quality and consistency of
the OMIM to MeSH mappings, the ability of the vocabulary
to be modified to meet needs other than those for
which it was originally created and ongoing maintenance
requirements.
Breadth of coverage
Breadth of coverage refers to the extent to which an ontol-
ogy covers a particular set of concepts. To determine the
breadth of coverage, the full set of OMIM diseases in use at
MGI was compared with the 4049 OMIM terms included in
MEDIC at the time of analysis. This analysis was conducted
twice. The first analysis defined OMIM terms used by MGI as
any OMIM term loaded into MGI, regardless of whether or
not the term had any associated mouse model or mouse
gene. The first analysis, conducted in June 2010, identified
347 OMIM terms in MGI, which were absent from MEDIC.
Two hundred and fifty-nine of these were in CTD’s set of
OMIM terms, which had been reviewed but not mapped to
any MeSH term. Of these 259, 214 were determined to rep-
resent phenotypes or unmapped genes and not diseases.
As a result, these OMIM terms were excluded from the
set of OMIM terms displayed in MGI. About 30 of the 259
were either chromosome aberration syndromes (29) or dis-
eases (1) with only very general symptom descriptions.
These were determined to be of low priority based on
the presumed low probability of the development of
mouse models for these diseases and therefore left un-
mapped. An advantage of this vocabulary is the ease with
which these OMIM terms could be added if a mouse model
was ever identified. The final 15 OMIM terms in the un-
mapped set of 259 were mapped to MeSH terms. The re-
maining 88 terms from the original 347 were either new
OMIM terms or OMIM terms without an associated gene
(which were not part of the initial objectives of the vocabu-
lary). All of these were individually mapped to at least
one MeSH term, in an updated version of the vocabulary.
From this first analysis then only 103 OMIM terms (15 plus
88) necessary for MGI curation were missing from the
4049 OMIM terms in MEDIC at the time of analysis, repre-
senting a deficiency in breadth of coverage of only 2.5%
(103/4049).
A second analysis, conducted in August 2010, defined
OMIM terms used in MGI as terms with either an associated
mouse model or mouse gene. This analysis identified an
additional 212 terms in MGI but absent from MEDIC.
Of the 212, 37 were repeats from the first analysis.
These 37 were all terms that had been rejected in the
first analysis either as low priority unmapped terms or
terms that should be excluded. Of the remaining 175, 90
were new OMIM terms that had not yet been mapped and
the remaining 85 were existing OMIM terms without an
associated gene (which were not part of the initial object-
ives of the vocabulary). All 175 unmapped OMIM terms
were then examined and either mapped to appropriate
MeSH terms or added to the unmapped term set. Of the
175, 12 were identified as not being disease terms
and placed in the unmapped term set. The remaining
163 were individually mapped to at least one MeSH term.
All additional mappings were added to an updated version
of the vocabulary. In this second analysis then only 85
OMIM terms necessary for MGI curation were found miss-
ing, again representing a small deficiency in breadth of
coverage.
Both analyses determined that CTD’s scope for MEDIC,
OMIM disease terms with an associated human gene, was
not sufficient to meet all of MGI’s disease curation needs.
However, the additional terms needed could be readily
identified and the creation of the additional MeSH map-
pings will require minimal periodic MGI curator time
(around one curator day per quarterly update).
Depth of coverage
Depth of coverage refers to the precision of the vocabulary
terms, or the level of detail (specificity) within an ontology.
As MEDIC was originally created, OMIM terms that were of
the type ‘Disease Name #’ (e.g. AGAMMAGLOBULINEMIA 1,
601495; AGAMMAGLOBULINEMIA 6, 612692) were
merged into the generic MeSH term for that disease (e.g.
Agammaglobulinemia, D000361). This compression of the
more specific disease terms is undesirable at MGI where a
distinction is defined between mouse models with similar
or differing etiology compared to the human disease.
Again the vocabulary proved to be easily modified to
meet MGI’s needs. The mappings of OMIM to MeSH are
maintained with a field indicating whether an OMIM
term should be merged with (M) or made a child of (L) a
MeSH term. An MGI-specific field (MGI_Action_CD) was
added to allow for differing levels of term specificity. For
example, in Figure 3A the MGI field specifies that the
OMIM terms Alagille syndrome 1 and Alagille syndrome 2
should be made children of the MeSH term Alagille
.............................................................................................................................................................................................................................................................................................
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should be merged with Alagille syndrome. Similarly in
CTD, the OMIM terms Aicardi–Goutieres syndromes 1–4
are merged with the MeSH term Aicardi–Goutieres syn-
drome (Figure 3B), while in MGI the OMIM terms are
made children of the MeSH term (Figure 3C). However, in
both the MGI and CTD versions the OMIM term Aicardi–
Goutieres syndrome 5 is merged with the lexically identical
MeSH term Aicardi–Goutieres syndrome 5. In all, MGI
required approximately 740 terms to be added as children
of MeSH terms where CTD had merged the OMIM term
into the MeSH term. This difference resulted in creation
of an MGI-specific variant of MEDIC. Both versions con-
tain the same terms and differ only in the merge/child or-
ganizational structure described above. The extended
version of the vocabulary is available in Open Biomedical
Ontology (OBO) format at ftp://ftp.informatics.jax.org/pub/
mosh. As MeSH does not use defined relationships between
terms, the OBO-formatted file was created assuming all re-
lationships are ‘is_a’ relationships.
Figure 3. (A) Section of the OMIM to MeSH mapping spreadsheet. Arrow indicates the MGI-specific field (MGI_Action_CD) used
to generate the extended version of MEDIC. M, merge; L, leaf. (B) Graphical display of the OMIM terms Aicardi–Goutieres
syndromes 1–4 within MEDIC, all four OMIM terms are merged with the MeSH term Aicardi–Goutieres syndrome.
(C) Graphical display of the OMIM terms Aicardi–Goutieres syndromes 1–4 within MEDIC as used at MGI, all four OMIM terms
are child terms to the MeSH term Aicardi–Goutieres syndrome.
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Most OMIM terms are readily mapped to MeSH terms based
on lexical similarity. For example AGAMMAGLOBULINEMIA
1 (601495) maps to the MeSH term Agammaglobulinemia
(D000361) and PARKINSON DISEASE, LATE-ONSET (168600)
maps to the MeSH term Parkinson Disease (D010300). These
mappings are all of high quality and highly consistent.
These lexical mappings constitute the majority of the
OMIM to MeSH mappings. Many of the OMIM terms that
do not have a good lexical match in MeSH are for complex
syndromes. Disease symptoms are identified from all avail-
able information in OMIM, e.g. clinical synopses, disease
descriptions. By adopting a straightforward mapping of
symptom to disease class, a high level of consistency can
be maintained for these mappings. For example, the clinical
synopsis for the disease OCULOAURICULAR SYNDROME
(OMIM 612109) lists symptoms involving the subcategories
ears and eyes. Therefore, this disease is mapped to
the MeSH terms Ear Diseases (D004427) and Eye
Abnormalities (D005124). In addition, for syndromes with
less informative names symptom-based mapping may be
informative for users. For example, mapping the OMIM
term RIDDLE SYNDROME (611943) to the MeSH terms for
its symptoms (immune deficiency syndromes, learning dis-
orders and facies) provides insights into the disease.
Not all symptom-based mappings are as straight forward
as that of OCULOAURICULAR SYNDROME. There are two
main pitfalls of symptom-based mappings. First, because a
disease may produce a symptom in an organ or tissue it
does not necessarily mean that all types of that disease
are a disease of that organ or tissue. For example, in
MeSH, albinism is a child of eye diseases and pigmentation
diseases, while experts would agree that albinism is a pig-
mentation disease, not all forms of albinism are eye dis-
eases. For example, piebaldism is a child of albinism and
therefore a child of eye diseases but does not have an
eye phenotype. Second, some symptom descriptions may
lead to erroneous mappings if the mapping is not con-
structed or reviewed by an expert clinician. Symptoms
described as being ‘like’ some other disease or syndrome,
may be lexically, yet erroneously, mapped to that disease.
For example, patients with Lujan–Fryns syndrome are
described as having ‘Marfanoid habitus’, a term lexically
related to the term ‘Marfan’ but whose definition is not
related to Marfan syndrome. The symptom-based associ-
ation assertion results in a mapping of Lujan–Fyrns
syndrome to Marfan syndrome, which is incorrect. These
kinds of situations require experts in disease phenotypes
to identify, review and curate. Such clinical experts must
be an integral part of any disease ontology development
effort.
Despite these potential pitfalls, the vast majority of the
OMIM to MeSH mappings in MEDIC were found to be highly
consistent and of very good quality. In addition, as MeSH
adds more syndromes to its vocabulary, the reliance on
symptom-based mapping inMEDICis reduced. The potential
problems with symptom-based mapping, while important
to consider, were not determined to be of sufficient signifi-
cance to deter the use of either version of the vocabulary.
Application of the extended vocabulary to MGI’s
annotations
With the addition of the identified missing OMIM terms
and changes to the organizational structure, the extended
version of MEDIC covers all mouse models of human disease
currently annotated to an OMIM term in MGI. This left the
set of mouse models that could not be annotated to an
OMIM term. As of May 2011, there were over 250 such
mouse models. Based on the existing text annotations, all
of these models could be annotated to a term in the
extended vocabulary. Most annotations are to general dis-
ease terms in MeSH such as Parkinson Disease (D010300) or
inflammatory Bowel Diseases (D015212). A smaller set of
annotations are associated to high level MeSH terms, e.g.
a mouse model of congenital obstructive nephropathy (7)
can be annotated to Kidney Diseases (D007674). These an-
notations may be useful to ontology developers to identify
areas for possible term expansion.
Maintenance of the extended version of MEDIC
Ongoing curation is required to maintain the extended ver-
sion of the merged vocabulary. Many of the maintenance
requirements will be shared with CTD. For example, identi-
fication of changes in MeSH and OMIM, which require cura-
torial attention will be done using shared automated
quality control processes. Modifications or additions to
the OMIM to MeSH mappings for both versions of the vo-
cabulary may be done simultaneously using a shared map-
ping file. The use of a shared mapping file will ensure that
both versions of the vocabulary stay in sync. The actual
merge process to generate the extended version and all
post-merge quality control processes will need to be done
at MGI. However, outputs from these quality control pro-
cesses can feedback into the shared mapping file and thus
improve the overall disease terminology.
As the merged vocabulary does not include all possible
OMIM disease terms, ongoing curation will be required to
add in existing OMIM disease terms that were not originally
incorporated into the vocabulary and not identified as ne-
cessary to meet MGI’s current curation needs in this review.
There are 2200 OMIM potential disease terms that are
not either in the mapping file or excluded from the map-
ping file for not being a disease. Not all of these terms
are expected to be disease terms, some may be phenotype
or enzyme activity terms (e.g. OCULAR DOMINANCE,
164190; THEOPHYLLINE BIOTRANSFORMATION, 187650).
If a mouse model for one of the excluded diseases is
.............................................................................................................................................................................................................................................................................................
Page 6 of 7
Original article Database, Vol. 2012, Article ID bar063, doi:10.1093/database/bar063
.............................................................................................................................................................................................................................................................................................identified it will be readily added to the mapping file for
inclusion in the merged vocabulary. We would also recom-
mend the creation of a tracking system, such as a
SourceForge tracker, so that other groups outside of CTD
and MGI may suggest additional OMIM terms to add or
other changes. New OMIM disease terms are identified
and incorporated as part of the current ongoing curation
of MEDIC.
Current use of OMIM at MGI requires ongoing quality
control and annotation updates. The most time consuming
part of this work is the incorporation of updates to anno-
tations required when OMIM refines the definition of a
term. For example, in the past, OMIM changed the term
PARKINSON DISEASE into the term PARKINSON DISEASE,
LATE-ONSET. This required extensive annotation review
and modifications of existing records to ensure annotations
were consistent with this change. As well, OMIM is working
to separate the phenotype and gene records (those pre-
fixed with a+in OMIM) into individual gene (prefixed
with a * in OMIM) and phenotype (prefixed with a # in
OMIM) records. These changes also require modifications
to MGI annotations. It is expected that adoption of the ex-
tended version of MEDIC will avoid the need to modify and
update annotations, providing for a substantial curatorial
time savings. For example, had the extended vocabulary
been in use when OMIM changed the term PARKINSON
DISEASE into the term PARKINSON DISEASE, LATE-ONSET,
updates to the extended vocabulary would have been
made to reflect the term change, but annotations to the
MeSH term Parkinson Disease (D010300) would not have
required review.
Conclusions
With the future development of a formal disease ontology
uncertain, a merger of disease terms from MeSH and OMIM
is a viable, practical solution to a pressing curation need.
The merger of MeSH and OMIM allows access to highly
detailed OMIM disease records and to the hierarchical
structure and generic disease terms in MeSH. The vast ma-
jority of OMIM to MeSH mappings in the merged vocabu-
lary are of high quality and consistency. The expanded
scope and specificity of the extended version of MEDIC is
able to cover all of the MGI’s disease model curation needs
and the process for updating and adding new mappings is
quick and easy. In addition to full coverage of MGI’s exist-
ing disease model annotations, access to the MeSH hier-
archy allows for retrieval of disease model sets, such as all
mouse models of Parkinson disease, not currently possible
using OMIM alone. The use of existing vocabularies (MeSH
and OMIM) makes excellent use of available resources.
In addition, both versions of the vocabulary are able to
inform development of more formal disease ontologies
providing developers with a highly curated set of OMIM
to MeSH relationships. In this vein, a file containing the
extended version of MEDIC in OBO format is available
from MGI (ftp://ftp.informatics.jax.org/pub/mosh) and we
encourage developers of disease ontologies to use this as
the basis of their MeSH to OMIM relationships. The incorp-
oration of OMIM and MeSH identifiers into developing dis-
ease ontologies will greatly aid in adoption of the ontology
by databases, such as CTD and MGI, as it will facilitate mi-
gration of existing annotations to the new ontology.
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